Should we wait for magnetic resonance imaging before administering intravenous alteplase for acute ischemic stroke?

Should We Wait for MRI for Thrombolysis in Stroke?

No, do not wait for MRI before administering IV alteplase for acute ischemic stroke within the standard treatment window—use non-contrast CT to exclude hemorrhage and proceed immediately with thrombolysis if eligible. Time is brain, and any imaging that delays treatment administration reduces the benefit of thrombolysis.

The Core Principle: CT First, Treat Fast

For patients presenting within 4.5 hours of symptom onset, either non-contrast CT (NECT) or MRI is acceptable to exclude intracranial hemorrhage before administering IV alteplase 1. However, the 2018 AHA/ASA guidelines and 2009 imaging recommendations emphasize that MRI should only be used if it does not unduly delay alteplase administration 1.

Why CT Remains the Standard

• Accessibility: CT is more widely available and faster to obtain than MRI
• Speed: CT can be completed in minutes, while MRI typically requires 15-30 minutes or longer
• Sufficient for decision-making: CT effectively excludes hemorrhage (the absolute contraindication) and identifies extensive hypodensity (relative contraindication)
• Proven efficacy: All major thrombolysis trials establishing alteplase's benefit used CT-based selection 2

When MRI May Be Considered (Without Delay)

MRI can be used for initial evaluation only if:

1. It does not delay alteplase administration 1
2. The institution has immediate MRI access with stroke-optimized protocols
3. The patient can be safely scanned (no pacemaker, claustrophobia, etc.)

MRI advantages include superior detection of:

• Acute ischemia (DWI has very high sensitivity/specificity) 1
• Stroke mimics (reducing unnecessary treatment)
• Small or posterior fossa infarcts
• Microhemorrhages (though <5 microbleeds are not a contraindication) 1

The Extended Window Exception: When MRI Becomes Essential

Beyond 4.5 hours from symptom onset or for wake-up strokes, advanced imaging with MRI becomes the preferred selection tool:

• DWI-FLAIR mismatch (positive DWI, negative FLAIR) identifies patients likely within a treatable window 3, 4
• Perfusion imaging (MRI-PWI or CT perfusion) identifies salvageable tissue 5, 6
• Multiple RCTs (WAKE-UP, EXTEND, THAWS) demonstrated that MRI-guided or perfusion-guided selection enables safe and effective thrombolysis 4.5-9 hours after onset 7, 8, 3

In this extended window scenario, the imaging is the selection criterion—you cannot proceed without it.

Critical Pitfalls to Avoid

1. Never delay treatment to obtain "better" imaging: Every 15-minute delay reduces the odds of good outcome. If CT is available now and MRI requires waiting, use CT 1

2. Don't confuse early ischemic changes with contraindications: Early CT signs of infarction (loss of gray-white differentiation, subtle hypodensity) are NOT contraindications to alteplase. Only frank hypodensity involving >1/3 of MCA territory is a strong contraindication 1

3. Recognize that vascular imaging (CTA/MRA) is optional in the acute window: While helpful for planning thrombectomy, vascular imaging should not delay IV alteplase unless an endovascular team is immediately available to potentially change management 1

The Algorithm

For patients presenting ≤4.5 hours from onset:

• Obtain non-contrast CT immediately
• Exclude hemorrhage
• Check for extensive hypodensity (>1/3 MCA territory)
• If negative → administer alteplase
• Do NOT wait for MRI

For patients presenting >4.5 hours or wake-up stroke:

• Obtain MRI with DWI-FLAIR or perfusion imaging (MRI-PWI or CT perfusion)
• Look for DWI-FLAIR mismatch OR perfusion-diffusion mismatch
• If mismatch present → administer alteplase (up to 9 hours) 7, 8, 5

For patients with unknown onset time:

• MRI with DWI-FLAIR mismatch can identify candidates for thrombolysis 3, 4
• This represents a tissue-based rather than time-based selection

The Evidence Hierarchy

The strongest guideline evidence 2, 1 consistently prioritizes speed over imaging sophistication within the standard window. Recent high-quality RCTs 7, 5, 3 have expanded the role of MRI for extended-window selection, but this represents a different clinical scenario where advanced imaging enables treatment that would otherwise be contraindicated by time alone.

The bottom line: In acute stroke, the enemy is delay. Use the fastest available imaging that excludes hemorrhage and proceed to treatment. MRI is a tool for expanding treatment eligibility beyond traditional windows, not a requirement that should delay standard care.